M.D. Sass LLC’s GCI Liberty, Inc. Class A-1 Common Stock GNCMA Stock Holding History

M.D. Sass LLC’s Portfolio GNCMA Stock Details GNCMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-192,000	Closed	-$7.49M	–	55
2017 Q4	$7.49M	Buy	192,000 +19,000	+11%	+$775K	0.67%	34
2017 Q3	$7.06M	Buy	+173,000	New	+$7.07M	0.59%	38

Other funds holding GNCMA

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

M.D. Sass LLC's GNCMA Position: Q1 2018 in Review

M.D. Sass LLC sold out of GCI Liberty, Inc. Class A-1 Common Stock (GNCMA) in Q1 2018, closing a stake of 192,000 shares — an estimated $7.49M sold.

M.D. Sass LLC first reported a position in GNCMA in Q3 2017 and held it in 2 quarters. The position peaked at $7.49M in Q4 2017. 2 funds tracked by Wall St. Rank hold GNCMA as of Q1 2018.

M.D. Sass LLC reported no remaining GCI Liberty, Inc. Class A-1 Common Stock position as of Q1 2018 after selling out during the quarter.
M.D. Sass LLC sold 192,000 GCI Liberty, Inc. Class A-1 Common Stock shares in Q1 2018, an estimated $7.49M.
M.D. Sass LLC first reported a position in GCI Liberty, Inc. Class A-1 Common Stock in Q3 2017 and held it in 2 quarters.
M.D. Sass LLC's GCI Liberty, Inc. Class A-1 Common Stock position peaked at $7.49M in Q4 2017.
2 funds tracked by Wall St. Rank held GCI Liberty, Inc. Class A-1 Common Stock as of Q1 2018.

Based on M.D. Sass LLC's 13F filing for Q1 2018, filed 14 May 2018.